| Net Cash Provided by (Used in) Operating Activities |
-12.8K |
USD |
+55.3% |
Q4 2023 |
Q1 2024 |
| Net Cash Provided by (Used in) Financing Activities |
-34.6K |
USD |
-188% |
Q4 2023 |
Q1 2024 |
| Common Stock, Shares Authorized |
500M |
shares |
0% |
Q4 2023 |
Q1 2024 |
| Common Stock, Shares, Issued |
112M |
shares |
0% |
Q4 2023 |
Q1 2024 |
| Common Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
Q1 2024 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
-47.4K |
USD |
-550% |
Q4 2023 |
Q1 2024 |
| Deferred Tax Assets, Valuation Allowance |
465K |
USD |
+5.7% |
Q3 2023 |
FY 2023 |
| Deferred Tax Assets, Operating Loss Carryforwards |
465K |
USD |
+5.7% |
Q3 2023 |
FY 2023 |
| Preferred Stock, Shares Issued |
0 |
shares |
|
Q4 2023 |
Q1 2024 |
| Preferred Stock, Shares Authorized |
100M |
shares |
0% |
Q4 2023 |
Q1 2024 |
| Additional Paid in Capital |
1.04M |
USD |
0% |
Q4 2023 |
Q1 2024 |
| Preferred Stock, Shares Outstanding |
0 |
shares |
|
Q4 2023 |
Q1 2024 |
| Interest Expense |
52.4K |
USD |
+35.9% |
Q4 2023 |
Q1 2024 |
| Preferred Stock, Par or Stated Value Per Share |
0 |
USD/shares |
0% |
Q4 2023 |
Q1 2024 |